Therapeutic efficacy of antibodies lacking FcgammaR against lethal Dengue virus infection Is due to neutralizing potency and blocking of enhancing antibodies

Authors

Katherine L. Williams, University of California - Berkeley
Soila Sukupolvi-Petty, Washington University School of Medicine in St. Louis
Martina Beltramello, Institute for Research in Biomedicine, Bellinzona, Switzerland
Syd Johnson, Macrogenics, Inc., Rockville, Maryland
Federica Sallusto, Institute for Research in Biomedicine, Bellinzona, Switzerland
Antonio Lanzavecchia, Institute for Research in Biomedicine, Bellinzona, Switzerland
Michael S. Diamond, Washington University School of Medicine in St. LouisFollow
Eva Harris, University of California - Berkeley

Journal

PLoS Pathogens

Publication Date

2013

Volume

9

Issue

2

Inclusive Pages

e1003157

Document Type

Open Access Publication

DOI

10.1371/journal.ppat.1003157

Rights and Permissions

Williams KL, Sukupolvi-Petty S, Beltramello M, Johnson S, Sallusto F, et al. (2013) Therapeutic Efficacy of Antibodies Lacking FcγR against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies. PLoS Pathog 9(2): e1003157. doi:10.1371/journal.ppat.1003157

Recommended Citation

Williams, Katherine L.; Sukupolvi-Petty, Soila; Beltramello, Martina; Johnson, Syd; Sallusto, Federica; Lanzavecchia, Antonio; Diamond, Michael S.; and Harris, Eva, "Therapeutic efficacy of antibodies lacking FcgammaR against lethal Dengue virus infection Is due to neutralizing potency and blocking of enhancing antibodies." PLoS Pathogens. 9, 2. e1003157. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/1388